Kevin Feeley - Apr 9, 2025 Form 4 Insider Report for GeneDx Holdings Corp. (WGS)

Signature
/s/ Bridget Brown, Attorney-in-Fact
Stock symbol
WGS
Transactions as of
Apr 9, 2025
Transactions value $
-$1,389,628
Form type
4
Date filed
4/10/2025, 04:12 PM
Previous filing
Mar 28, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WGS Class A Common Stock Options Exercise $40.7K +1.25K +7.79% $32.67 17.2K Apr 9, 2025 Direct
transaction WGS Class A Common Stock Sale -$53.3K -637 -3.69% $83.67 16.6K Apr 9, 2025 Direct F1, F2
transaction WGS Class A Common Stock Sale -$101K -1.2K -7.21% $84.61 15.4K Apr 9, 2025 Direct F1, F3
transaction WGS Class A Common Stock Sale -$100K -1.17K -7.6% $85.73 14.2K Apr 9, 2025 Direct F1, F4
transaction WGS Class A Common Stock Sale -$21.5K -249 -1.75% $86.48 14K Apr 9, 2025 Direct F1
transaction WGS Class A Common Stock Sale -$635K -6.81K -48.69% $93.26 7.18K Apr 9, 2025 Direct F1, F5
transaction WGS Class A Common Stock Sale -$295K -3.12K -43.5% $94.60 4.06K Apr 9, 2025 Direct F1, F6
transaction WGS Class A Common Stock Sale -$140K -1.46K -36.08% $95.53 2.59K Apr 9, 2025 Direct F1, F7
transaction WGS Class A Common Stock Sale -$81.6K -846 -32.64% $96.46 1.75K Apr 9, 2025 Direct F1, F8
transaction WGS Class A Common Stock Sale -$1.95K -20 -1.15% $97.26 1.73K Apr 9, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WGS Employee Stock Option (Right to Buy) Options Exercise $0 -1.25K -14.29% $0.00 7.47K Apr 9, 2025 Common Stock 1.25K $32.67 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2024.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.07 to $84.00 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.13 to $84.98 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.25 to $86.14 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.00 to $93.99 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.00 to $94.98 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.04 to $96.03 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F8 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.07 to $96.96 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F9 6.25% vest in quarterly installments over the 4-year period commencing on December 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date